Soiken Holdings Inc.

2385

JP3431850001

Personal Products

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
168 ^JPY	-1.18%		+1.20%	0.00%

2023	Soiken Holdings Inc. Reports Earnings Results for the Nine Months Ended March 31, 2023	CI
2021	Hangzhou Golong Holding Co., Ltd. agreed to acquire 10.7% stake in Soiken Holdings Inc. from Tomoko Kajimoto for ?1.1 billion.	CI

Soiken Holdings Inc. cancelled the acquisition of 15.1% stake in Trans-Asia Inc. from Tomonori Mori.

September 12, 2015 at 12:00 am EDT

Soiken Holdings Inc. (TSE:2385) agreed to acquire 15.1% stake in Trans-Asia Inc. from Tomonori Mori for ¥20 million on September 12, 2014. Under the terms of the transaction, Soiken Holdings Inc. will acquire 1,600 million shares at price of ¥12,500 per share. The transaction is scheduled to complete on September 12, 2014.

Soiken Holdings Inc. (TSE:2385) cancelled the acquisition of 15.1% stake in Trans-Asia Inc. from Tomonori Mori on September 12, 2015.

Latest news about Soiken Holdings Inc.

Soiken Holdings Inc. Reports Earnings Results for the Nine Months Ended March 31, 2023	23-05-11	CI
Hangzhou Golong Holding Co., Ltd. agreed to acquire 10.7% stake in Soiken Holdings Inc. from Tomoko Kajimoto for ?1.1 billion.	21-11-16	CI
Soiken Holdings Inc.(TSE:2385) dropped from S&P Global BMI Index	21-09-20	CI
Soiken Holdings Inc.(TSE:2385) added to S&P Global BMI Index	18-09-24	CI
Soiken Holdings Inc. completed the acquisition of 64.5% stake in Nrl Pharma, Inc from Nobuko Ando, Hiroshi Koike, Jiro Yoshimura, Tatsuo Hoshino, Masao Hara and Kazuhiro Kaneko for approximately ¥570 million.	17-06-26	CI
Soiken Holdings Inc. signed a contract to acquire 58.6% stake in Nrl Pharma, Inc from Nobuko Ando, Hiroshi Koike, Jiro Yoshimura, Tatsuo Hoshino, Masao Hara and Kazuhiro Kaneko for approximately ¥500 million.	17-05-18	CI
Beautyplus Holdings Hongkong Limited cancelled the acquisition of 15% stake in BB Laboratories Incorporated from Soiken Holdings Inc..	16-05-26	CI
Soiken Holdings Inc. cancelled the acquisition of 15.1% stake in Trans-Asia Inc. from Tomonori Mori.	15-09-12	CI
Beautyplus Holdings Hongkong Limited agreed to acquire 15% stake in BB Laboratories Incorporated from Soiken Holdings Inc. for ¥120 million.	15-05-28	CI
Soiken Holdings Inc. agreed to acquire Trans-Asia Inc. for JPY 20 million.	14-09-12	CI

Chart Soiken Holdings Inc.

Duration

Period

More charts

Company Profile

Soiken Holdings Inc. is a Japan-based holding company. The Company operates in six business segments. The Biological Evaluation System segment is engaged in evaluation test of food and research support of medicine. The Healthcare Support segment is engaged in the provision of service about certain health guidance and healthcare insurance. The Cosmetics segment is engaged in manufacturing and sales of cosmetics. The Dietary Supplements segment is engaged in sales of unique dietary supplements. The Marketing segment is engaged in the marketing research of health supplement and sales of energy drink. The Functional Material Development segment is engaged in development and sales of functional materials, such as lactoferrin.

Sector

Personal Products

Calendar

2024-05-12 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Soiken Holdings Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
SOIKEN HOLDINGS INC.	0.00%	28.59M
L'ORÉAL	-3.63%	250B
KAO CORPORATION	+10.09%	19.15B
GALDERMA GROUP AG	0.00%	17.54B
SHISEIDO COMPANY, LIMITED	-1.32%	10.84B
COTY INC.	-7.85%	10.22B
AMOREPACIFIC CORPORATION	+0.76%	6.53B
PROYA COSMETICS CO.,LTD.	+10.78%	6B
NATURA &CO HOLDING S.A.	-0.89%	4.41B
INTER PARFUMS, INC.	-18.35%	3.78B

Cosmetics & Perfumes